GSK profit rises to £5.7bn as speciality medicines drive growth
GSK's net profit surged to £5.7 billion, primarily fueled by strong sales in specialty medicines like HIV and cancer drugs, as the company rebounds from previous legal challenges.
A compact global news feed for the bigger picture.
GSK's net profit surged to £5.7 billion, primarily fueled by strong sales in specialty medicines like HIV and cancer drugs, as the company rebounds from previous legal challenges.
Loading Intelligence...
Select a report from the feed to view analysis and related coverage.
A compact global news feed for the bigger picture. It pulls reporting from outlets around the world so you can compare what gets covered, what gets missed, and how it’s framed.
It can feel dense at first (on purpose): more signal, less fluff. No ads. No trackers. No agenda.